18+

CELLIVITY / ADULT ACCESS

Are you 18 or older?

CELLIVITY is available to adults only. Supplement pages are general product information; peptide records are not a sales offer and are not for human use.

Age confirmation is a declaration, not identity verification. Restricted research access still requires separate professional eligibility checks.Privacy and legal notice ↗
Skip to content
CELLIVITY
HomeScience LibraryEvidence methodologyResearch Radar
🇬🇧EN⌄
🇬🇧EnglishEN🇭🇺MagyarHU🇹🇭ไทยTH🇷🇺РусскийRU
Independent evidence
HomeScience LibraryEvidence methodologyResearch Radar
← Science Library

Medical

Metformin

Biguanide medicine

Guide-level evidence orientationEvidence level D

Level D describes sparse or indirect human evidence for this exact question; read the conclusion for direction and limits.

This guide-level grade is an orientation, not a direction-of-effect label, product grade, claim or personal recommendation.
ORIENTATION RECORDUseful starting context; question-specific review is still pending.

Do not treat the guide-level letter as a final conclusion, product claim or recommendation.

IN PLAIN LANGUAGE

Why people are interested

A medicine that lowers liver glucose output and changes cellular energy signalling. Its established role is metabolic care, not general anti-ageing use.

Library trackMedical research
Last reviewed20 Aug 2026
Guide scopeIngredient research only
01

How it may work

A prescription glucose-lowering medicine with effects on hepatic glucose production and cellular energy sensing.

02

What people have studied

Clinical benefit is established for indicated metabolic disease, not for routine use as an anti-ageing drug in healthy people.

03

What to consider

Prescription-only medical supervision is essential; contraindications and B12 monitoring matter.

04

Local pathway

Medical/prescription pathway only. Not a CELLIVITY consumer product.

Sources + indexes

See where the explanation comes from.

Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.

  1. 01metformin aging — PubMed research index ↗
CELLIVITY

Independent evidence guides for human research.

Science LibraryHomeScience LibraryEvidence methodologyResearch Radar
BoundariesLegal and privacySafety boundariesPrivacy request / unsubscribe
Pre-release boundary

Unless a page explicitly says released, every product is a development record. No page confirms approval, stock, individual suitability or medical benefit. Educational content is not medical advice.

Full legal terms →
© 2026 CELLIVITY. Pre-launch.Riviera Jomtien, 29/111, Pattaya 20150, ThailandControlled contact route

CELLIVITY / STAY IN THE LOOP

Follow the next
chapter.

New product records, laboratory documents and release news. Choose to hear from us when there is something useful to share.

  • New laboratory documents
  • Product availability updates
  • News from CELLIVITY
18+ only. Optional email updates. You can unsubscribe at any time.
Metformin — CELLIVITY Science Library